Lijun Yang

ORCID: 0000-0002-9907-5875 · 5 papers in corpus
review 2026
Research (Washington, D.C.) ·doi:10.34133/research.1106

Metabolism-regulating microspheres have evolved from conventional drug carriers into active platforms capable of spatiotemporally reprogramming pathological metabolic networks. Chronic diseases are increasingly understood to be driven by me…

lab-animal 2025
Bioactive materials ·doi:10.1016/j.bioactmat.2025.04.007

Endometrial injury and resulting female infertility pose significant clinical challenges due to the notable shortcomings of traditional treatments. Herein, we proposed a double network composite hydrogel, CSMA-RC-Zn-PNS, which forms a physi…

observational 2025
Scientific reports ·doi:10.1038/s41598-025-13436-y

High-intensity focused ultrasound (HIFU) ablation is a minimally invasive treatment for benign gynecological diseases, though skin burns remain a potential complication. Understanding risk factors is critical for improving safety. In this s…

nonrandomized-trial 2022
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2022.2161641

OBJECTIVE: To evaluate the clinical efficacy of the combination of high-intensity focused ultrasound (HIFU), mifepristone, and levonorgestrel-releasing intrauterine system (LNG-IUS) in adenomyosis treatment. METHODS: HIFU treatment was per…

case-report 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.966620

Adenomyosis is a benign uterine disease. Due to the higher incidence of adenomyosis and patients' demands for fertility, high-intensity ultrasound ablation has been widely used in gynecological patients with uterine fibroids and adenomyosis…